10x Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 11, 2024. The filing details the voting outcomes for four proposals submitted to shareholders. Approximately 93.10% of eligible votes were present virtually or by proxy, establishing a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
- Proposal 1 (Election of Directors): Approved. Kimberly J. Popovits was elected as a Class II director. Votes For: 198,553,136; Votes Against: 18,689,301.
- Proposal 2 (Ratification of Auditors): Approved. Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For: 228,845,897; Votes Against: 174,119.
- Proposal 3 (Bylaw Amendment): Not Approved. Stockholders rejected an amendment that would have permitted the Board of Directors to amend the Company's Bylaws without requiring stockholder approval. Votes For: 112,727,437; Votes Against: 104,506,389.
- Proposal 4 (Executive Compensation): Approved. The non-binding advisory vote to approve executive compensation passed. Votes For: 180,775,070; Votes Against: 36,417,839.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The primary outcome of note is the rejection of the bylaw amendment, which maintains the requirement for stockholder approval for future bylaw changes.
Key Facts for Investor Verification
- Stockholders rejected the proposal to allow the Board to amend bylaws without shareholder approval, preserving shareholder control over governance changes.
- Kimberly J. Popovits was elected to the Board of Directors for a three-year term.
- Ernst & Young LLP was reappointed as the independent auditor.
- Executive compensation received majority support in the advisory vote, though a significant minority (approx. 16.8% of votes cast) opposed it.